Bristlecone Advisors LLC Has $4.19 Million Holdings in Danaher Co. (NYSE:DHR)

Bristlecone Advisors LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,250 shares of the conglomerate’s stock after selling 224 shares during the quarter. Bristlecone Advisors LLC’s holdings in Danaher were worth $4,189,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Quilter Plc raised its holdings in Danaher by 4.6% in the 4th quarter. Quilter Plc now owns 62,371 shares of the conglomerate’s stock worth $14,317,000 after acquiring an additional 2,746 shares during the period. Elevate Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth about $829,000. Angeles Wealth Management LLC increased its position in Danaher by 5.1% in the 4th quarter. Angeles Wealth Management LLC now owns 4,229 shares of the conglomerate’s stock worth $971,000 after buying an additional 204 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in shares of Danaher during the fourth quarter worth approximately $193,000. Finally, Kestra Private Wealth Services LLC increased its holdings in shares of Danaher by 11.2% during the 4th quarter. Kestra Private Wealth Services LLC now owns 17,480 shares of the conglomerate’s stock worth $4,013,000 after purchasing an additional 1,754 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Scotiabank began coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $206.92 on Monday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock’s fifty day moving average price is $232.72 and its two-hundred day moving average price is $251.70. Danaher Co. has a one year low of $205.79 and a one year high of $281.70. The firm has a market cap of $149.45 billion, a price-to-earnings ratio of 39.19, a P/E/G ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company earned $2.09 EPS. On average, equities analysts forecast that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.